 |
|
June 6, 2001
JAMA. 2001;285:2793-2794.
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.
Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.
CME Articles in This Issue of JAMA
The following articles in this issue may be read for CME credit:
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial2719
Educational Objective: To compare the effectiveness of 2 antihypertensive drugs for slowing the decline of renal function.
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study2729
Educational Objective: To learn that HDL-C levels may reduce older adults' risk of ischemic stroke.
Mortality and Locomotion 6 Months After Hospitalization for Hip Fracture: Risk Factors and Risk-Adjusted Hospital Outcomes2736
Educational Objective: To learn that functional status and mortality after hip fracture may have different prefracture predictors.
Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial2743
Educational Objective: To learn that enzyme replacement may benefit patients with Fabry disease.
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making2750
Educational Objective: To understand how life expectancy may affect decisions about cancer screening for older patients.
Stroke in a Healthy 46-Year-Old Man2757
Educational Objective: To review the diagnosis and treatment of stroke resulting from carotid artery dissection.
Tularemia as a Biological Weapon: Medical and Public Health Management2763
Educational Objective: To learn an expert panel's assessment of the potential effects of an airborne tularemia weapon.
After reading 3 of these articles, complete the CME Evaluation Form.
RELATED ARTICLES
|
Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: A Randomized Controlled Trial
Lawrence Y. Agodoa, Lawrence Appel, George L. Bakris, Gerald Beck, Jacques Bourgoignie, Josephine P. Briggs, Jeanne Charleston, DeAnna Cheek, William Cleveland, Janice G. Douglas, Margaret Douglas, Donna Dowie, Marquetta Faulkner, Avril Gabriel, Jennifer Gassman, Tom Greene, Yvette Hall, Lee Hebert, Leena Hiremath, Kenneth Jamerson, Carolyn J. Johnson, Joel Kopple, John Kusek, James Lash, Janice Lea, Julia B. Lewis, Michael Lipkowitz, Shaul Massry, John Middleton, Edgar R. Miller III, Keith Norris, Daniel O'Connor, Akinlou Ojo, Robert A. Phillips, Velvie Pogue, Mahboob Rahman, Otelio S. Randall, Stephen Rostand, Gerald Schulman, Winifred Smith, Denyse Thornley-Brown, C. Craig Tisher, Robert D. Toto, Jackson T. Wright, Jr, Shichen Xu, and for the African American Study of Kidney Disease and Hypertension Study Group
JAMA. 2001;285(21):2719-2728.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study
Ralph L. Sacco, Richard T. Benson, Douglas E. Kargman, Bernadette Boden-Albala, Catherine Tuck, I-Feng Lin, J. F. Cheng, Myunghee C. Paik, Steven Shea, and Lars Berglund
JAMA. 2001;285(21):2729-2735.
ABSTRACT
| FULL TEXT
Mortality and Locomotion 6 Months After Hospitalization for Hip Fracture: Risk Factors and Risk-Adjusted Hospital Outcomes
Edward L. Hannan, Jay Magaziner, Jason J. Wang, Elizabeth A. Eastwood, Stacey B. Silberzweig, Marvin Gilbert, R. Sean Morrison, Mary Ann McLaughlin, Gretchen M. Orosz, and Albert L. Siu
JAMA. 2001;285(21):2736-2742.
ABSTRACT
| FULL TEXT
Enzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin III, Sharda Sabnis, David F. Moore, Thais Weibel, James E. Balow, and Roscoe O. Brady
JAMA. 2001;285(21):2743-2749.
ABSTRACT
| FULL TEXT
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Louise C. Walter and Kenneth E. Covinsky
JAMA. 2001;285(21):2750-2756.
ABSTRACT
| FULL TEXT
Stroke in a Healthy 46-Year-Old Man
Robert J. Wityk
JAMA. 2001;285(21):2757-2762.
ABSTRACT
| FULL TEXT
Tularemia as a Biological Weapon: Medical and Public Health Management
David T. Dennis, Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward Eitzen, Anne D. Fine, Arthur M. Friedlander, Jerome Hauer, Marcelle Layton, Scott R. Lillibridge, Joseph E. McDade, Michael T. Osterholm, Tara O'Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, and for the Working Group on Civilian Biodefense
JAMA. 2001;285(21):2763-2773.
ABSTRACT
| FULL TEXT
|
